TrialCancer2011

A phase 2 study of temsirolimus (CCI-779) in patients with soft tissue sarcomas: a study of the Mayo phase 2 consortium (P2C).

Scott Okuno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.